tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

USFDA Completes Inspection at Dr. Reddy’s Facility with Observations

Story Highlights
  • Dr. Reddy’s Laboratories had a USFDA inspection at its Srikakulam facility in July 2025.
  • The inspection resulted in a Form 483 with seven observations to be addressed by the company.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
USFDA Completes Inspection at Dr. Reddy’s Facility with Observations

Elevate Your Investing Strategy:

An update from Dr Reddy’s Laboratories ( (RDY) ) is now available.

On July 18, 2025, Dr. Reddy’s Laboratories announced that the USFDA completed a GMP and Pre-Approval Inspection at its FTO 11 formulations manufacturing facility in Srikakulam, Andhra Pradesh. The inspection, conducted from July 10 to July 18, resulted in a Form 483 with seven observations, which the company plans to address within the stipulated timeline. This inspection is crucial for the company’s compliance and operational standards, potentially impacting its market positioning and stakeholder confidence.

The most recent analyst rating on (RDY) stock is a Buy with a $18.30 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.

Spark’s Take on RDY Stock

According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.

The overall stock score for Dr Reddy’s Laboratories is solid, driven primarily by strong financial performance, indicating robust growth and stable operations. However, technical analysis suggests bearish momentum, and the valuation indicates limited dividend income potential, which slightly dampens the overall score.

To see Spark’s full report on RDY stock, click here.

More about Dr Reddy’s Laboratories

Dr. Reddy’s Laboratories is a pharmaceutical company based in Hyderabad, India, known for its formulations, active pharmaceutical ingredients, and biologics. The company focuses on providing affordable and innovative medicines in various therapeutic areas, serving markets across the globe.

Average Trading Volume: 1,649,773

Technical Sentiment Signal: Strong Buy

Current Market Cap: $12.21B

See more insights into RDY stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1